整洁
发表于 2025-3-25 07:19:55
Book 2018Latest edition of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. An accompanying volume addresses the use of small molecules in oncology, and the two volumes together represent the third edition of the book originally published under the same title. .
压碎
发表于 2025-3-25 09:35:49
978-3-030-08256-7Springer International Publishing AG, part of Springer Nature 2018
欢呼
发表于 2025-3-25 12:33:31
http://reply.papertrans.cn/87/8685/868497/868497_23.png
一加就喷出
发表于 2025-3-25 16:45:42
Recent Results in Cancer Researchhttp://image.papertrans.cn/s/image/868497.jpg
thrombus
发表于 2025-3-25 22:37:02
https://doi.org/10.1007/978-3-319-91439-8Small Molecules; Molecular Mechanisms of Cancer; Targeted Therapy; Personalized Cancer Therapy; Protein
Nonthreatening
发表于 2025-3-26 00:52:55
http://reply.papertrans.cn/87/8685/868497/868497_26.png
dendrites
发表于 2025-3-26 07:36:50
Nilotinib,line treatment of chronic-phase chronic myeloid leukemia. By reaching deep and long-lasting molecular remissions, discontinuation of TKIs is becoming one of the central topics of future CML therapy. Stopping nilotinib seems safe and provides a stable remission in about half of the eligible patients, though long-term data are still missing.
Cabg318
发表于 2025-3-26 10:17:43
http://reply.papertrans.cn/87/8685/868497/868497_28.png
不爱防注射
发表于 2025-3-26 15:15:55
0080-0015 tion, drug targets, and drug interactions.Examines preclinic.This book, written by respected experts, discusses in detail the latest developments in targeted therapy for hematologic malignancies using small molecules. It covers a wide range of small molecules including tyrosine kinase inhibitors, im
臭了生气
发表于 2025-3-26 19:33:39
http://reply.papertrans.cn/87/8685/868497/868497_30.png